Susquehanna International Group
VIVO

Susquehanna International Group’s Meridian Bioscience Inc VIVO Stock Holding History

Susquehanna International Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,300
Closed -$1.15M – 14307
2022
Q3 		$1.15M Sell
36,300
-42,700
-54% -$1.38M ﹤0.01% 6289
2022
Q2 		$2.4M Sell
79,000
-15,100
-16% -$408K ﹤0.01% 4518
2022
Q1 		$2.44M Sell
94,100
-4,700
-5% -$112K ﹤0.01% 5030
2021
Q4 		$2.02M Buy
98,800
+21,100
+27% +$405K ﹤0.01% 5479
2021
Q3 		$1.5M Sell
77,700
-29,600
-28% -$590K ﹤0.01% 6495
2021
Q2 		$2.38M Sell
107,300
-60,600
-36% -$1.29M ﹤0.01% 5523
2021
Q1 		$4.41M Buy
167,900
+84,400
+101% +$2.01M ﹤0.01% 4156
2020
Q4 		$1.56M Buy
83,500
+35,600
+74% +$665K ﹤0.01% 5653
2020
Q3 		$813K Sell
47,900
-3,700
-7% -$71.9K ﹤0.01% 6632
2020
Q2 		$1.2M Buy
51,600
+41,100
+391% +$596K ﹤0.01% 5497
2020
Q1 		$88K Buy
+10,500
New +$88.4K ﹤0.01% 9399
2019
Q4 		– Sell
-18,800
Closed -$178K – 10946
2019
Q3 		$178K Sell
18,800
-12,800
-41% -$135K ﹤0.01% 9208
2019
Q2 		$375K Sell
31,600
-12,700
-29% -$153K ﹤0.01% 7870
2019
Q1 		$780K Sell
44,300
-21,900
-33% -$364K ﹤0.01% 5480
2018
Q4 		$1.15M Buy
66,200
+4,200
+7% +$71.6K ﹤0.01% 4425
2018
Q3 		$924K Sell
62,000
-34,600
-36% -$536K ﹤0.01% 5377
2018
Q2 		$1.54M Buy
96,600
+50,100
+108% +$747K ﹤0.01% 4498
2018
Q1 		$660K Buy
46,500
+23,100
+99% +$342K ﹤0.01% 6081
2017
Q4 		$328K Buy
23,400
+7,300
+45% +$107K ﹤0.01% 7443
2017
Q3 		$230K Sell
16,100
-19,300
-55% -$276K ﹤0.01% 7802
2017
Q2 		$558K Sell
35,400
-2,600
-7% -$37.5K ﹤0.01% 6440
2017
Q1 		$524K Buy
38,000
+9,700
+34% +$136K ﹤0.01% 6398
2016
Q4 		$501K Buy
28,300
+6,400
+29% +$112K ﹤0.01% 7001
2016
Q3 		$422K Sell
21,900
-20,700
-49% -$405K ﹤0.01% 6376
2016
Q2 		$831K Sell
42,600
-19,300
-31% -$378K ﹤0.01% 5226
2016
Q1 		$1.28M Sell
61,900
-68,900
-53% -$1.36M ﹤0.01% 4598
2015
Q4 		$2.68M Buy
130,800
+71,600
+121% +$1.37M ﹤0.01% 3494
2015
Q3 		$1.01M Buy
59,200
+26,500
+81% +$484K ﹤0.01% 5728
2015
Q2 		$610K Buy
32,700
+9,400
+40% +$174K ﹤0.01% 7236
2015
Q1 		$445K Buy
+23,300
New +$431K ﹤0.01% 7312
2014
Q4 		– Sell
-23,200
Closed -$410K – 10230
2014
Q3 		$410K Buy
23,200
+8,000
+53% +$157K ﹤0.01% 7553
2014
Q2 		$314K Buy
15,200
+1,000
+7% +$20.5K ﹤0.01% 8302
2014
Q1 		$309K Buy
+14,200
New +$325K ﹤0.01% 7544
2013
Q4 		– Sell
-17,100
Closed -$404K – 9461
2013
Q3 		$404K Sell
17,100
-2,400
-12% -$56K ﹤0.01% 6755
2013
Q2 		$419K Buy
+19,500
New +$421K ﹤0.01% 6307

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's VIVO Position: Q1 2023 in Review

Susquehanna International Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,318 shares — an estimated $608K sold.

Susquehanna International Group first reported a position in VIVO in Q4 2013 and held it in 24 quarters. The position peaked at $3.09M in Q2 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Susquehanna International Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 18,318 Meridian Bioscience Inc shares in Q1 2023, an estimated $608K.
  • Susquehanna International Group first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 24 quarters.
  • Susquehanna International Group's Meridian Bioscience Inc position peaked at $3.09M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.